Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Addictive Behaviors
|
May 5, 2000
Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study
J R Cornelius, I M Salloum, R F Haskett, et al.
The Journal of ECT
|
March 29, 2000
Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors
L S Boylan, R F Haskett, B H Mulsant, et al.
Archives of General Psychiatry
|
May 1, 1990
Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies
E A Young, S J Watson, J Kotun, et al.
Psychopharmacology Bulletin
|
May 2, 1998
Fluoxetine versus placebo in depressed alcoholic cocaine abusers
J R Cornelius, I M Salloum, M E Thase, et al.
The American Journal of Psychiatry
|
April 1, 1997
Low use of neuroleptic drugs in the treatment of psychotic major depression
B H Mulsant, R F Haskett, J Prudic, et al.
The American Journal of Psychiatry
|
August 1, 1996
Resistance to antidepressant medications and short-term clinical response to ECT
J Prudic, R F Haskett, B Mulsant, et al.
Psychopharmacology Bulletin
|
October 1, 1980
Neuroendocrine diagnostic criteria for depression [proceedings]
B J Carroll, M Feinberg, J F Greden, et al.
The Psychiatric Clinics of North America
|
April 1, 1981
Neuroendocrine evaluation of depression in borderline patients
B J Carroll, J F Greden, M Feinberg, et al.
The American Journal of Psychiatry
|
December 10, 1999
Acute efficacy of ECT in the treatment of major depression in the old-old
J D Tew, B H Mulsant, R F Haskett, et al.
JAMA
|
March 20, 2001
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial
H A Sackeim, R F Haskett, B H Mulsant, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Addictive Behaviors
|
May 5, 2000
Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study
J R Cornelius, I M Salloum, R F Haskett, et al.
The Journal of ECT
|
March 29, 2000
Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors
L S Boylan, R F Haskett, B H Mulsant, et al.
Archives of General Psychiatry
|
May 1, 1990
Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies
E A Young, S J Watson, J Kotun, et al.
Psychopharmacology Bulletin
|
May 2, 1998
Fluoxetine versus placebo in depressed alcoholic cocaine abusers
J R Cornelius, I M Salloum, M E Thase, et al.
The American Journal of Psychiatry
|
April 1, 1997
Low use of neuroleptic drugs in the treatment of psychotic major depression
B H Mulsant, R F Haskett, J Prudic, et al.
The American Journal of Psychiatry
|
August 1, 1996
Resistance to antidepressant medications and short-term clinical response to ECT
J Prudic, R F Haskett, B Mulsant, et al.
Psychopharmacology Bulletin
|
October 1, 1980
Neuroendocrine diagnostic criteria for depression [proceedings]
B J Carroll, M Feinberg, J F Greden, et al.
The Psychiatric Clinics of North America
|
April 1, 1981
Neuroendocrine evaluation of depression in borderline patients
B J Carroll, J F Greden, M Feinberg, et al.
The American Journal of Psychiatry
|
December 10, 1999
Acute efficacy of ECT in the treatment of major depression in the old-old
J D Tew, B H Mulsant, R F Haskett, et al.
JAMA
|
March 20, 2001
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial
H A Sackeim, R F Haskett, B H Mulsant, et al.
Page
of 8